Gynecomastia on TRT: Causes, Prevention, and Treatment
Learn why gynecomastia develops on testosterone replacement therapy, how elevated estradiol triggers breast tissue growth, and the evidence-based strategies to prevent and reverse it.
TRT vs Natural Boosters: Which Actually Raises Testosterone?
A clinical comparison of testosterone replacement therapy, enclomiphene, clomid, and natural supplements for low testosterone. Includes dosing, trial data, and guidance on cypionate vs enanthate vs gel.
How to Order Testosterone Injections Online Safely
A guide covering legal requirements, lab work, prescription protocols, pharmacy vetting, and injection safety for men seeking testosterone therapy online.
Metformin Future Formulations & Pipeline: What's Coming Beyond the Standard Tablet
A deep dive into metformin's next-generation formulations, pipeline compounds, extended-release mechanisms, and emerging combination strategies backed by primary clinical evidence.
Does Kaiser Permanente Cover Metformin?
A complete guide to Kaiser Permanente metformin coverage, formulary tier, prior authorization requirements, step therapy rules, and how to appeal a denial, with clinical context from UKPDS 34 and current ADA guidelines.
Metformin Dosing for Young Adults (Ages 18 to 29): A Complete Clinical Guide
Evidence-based metformin dosing guide for young adults aged 18 to 29, covering starting doses, titration schedules, fertility considerations, PCOS use, and ADA guidelines with primary source citations.
Metformin Safety in Young Adults (Ages 18 to 29): What Patients and Clinicians Need to Know
A comprehensive, evidence-based review of metformin safety for young adults aged 18, 29, covering dosing, side effects, contraindications, fertility, and long-term monitoring backed by clinical trial data.
Metformin Liver Function Impact: What the Evidence Actually Shows
A deep dive into how metformin affects the liver, including NAFLD, lactic acidosis risk, hepatic glucose output, and safety in liver disease. Backed by primary-literature citations throughout.
MK-677 (Ibutamoren) Complete Drug-Drug Interaction Profile
A guide to the mechanism-based interactions between MK-677 (ibutamoren) and insulin, oral hypoglycemics, glucocorticoids, thyroid hormones, CYP3A4-metabolized drugs, and IGF-1-sensitive cancer therapies, with an evidence-boundary summary for patients and clinicians.
MK-677 (Ibutamoren) Patent Field & Generic Timeline
A clinician-level breakdown of MK-677 (ibutamoren) patent expiry, generic availability prospects, mechanism of action, and what the regulatory void means for patients seeking GH secretagogue therapy.
Provigil How to Safely Stop: A Complete Modafinil Discontinuation Protocol
Learn how to safely stop modafinil (Provigil) with an evidence-based tapering protocol, withdrawal timeline, and clinical guidance from the HealthRX.com medical team.
MOTS-c History & Development: From Mitochondrial Discovery to Clinical Research
A deep dive into MOTS-c, the mitochondrial-derived peptide first identified in 2015. Covers discovery timeline, mechanism of action, preclinical data, and current research status.
MOTS-c Monitoring Schedule: Labs & Exams Every Patient Needs
A complete clinical guide to monitoring MOTS-c mitochondrial peptide therapy: which labs to order, when to order them, what values to watch, and how to adjust dosing based on results.
Mounjaro Complete Drug-Drug Interaction Profile
A physician-reviewed, PubMed-cited breakdown of every clinically significant drug-drug interaction for Mounjaro (tirzepatide): mechanism, pharmacokinetics, oral medication absorption, insulin and sulfonylurea risks, and real-world management strategies.
Mounjaro Travel & Timezone-Shift Protocols: The Complete Tirzepatide Guide
Everything you need to know about traveling with Mounjaro (tirzepatide): storage, dosing windows, timezone shifts, border crossings, and nausea management at altitude, with primary-literature citations.
Finasteride for Hirsutism: Off-Label Use, Evidence, and Monitoring
A guide to off-label finasteride for hirsutism: how it works, what the evidence shows, dosing, monitoring requirements, and contraindications.
Testosterone Cypionate for HIV Wasting: Off-Label Evidence Summary
A detailed clinical review of off-label testosterone cypionate use in HIV-associated wasting, covering trial evidence, dosing, safety, and GRADE-rated recommendations.
Ozempic Cardiovascular Impact Long-Term: What the Clinical Evidence Shows
A deep dive into semaglutide 0.5 to 2.0 mg and its long-term cardiovascular effects, covering SUSTAIN-6, SELECT, mechanism data, and practical clinical guidance for type 2 diabetes management.
Is Sermorelin Legal in Massachusetts? How to Access It Legally
A complete guide to Sermorelin's legal status in Massachusetts, covering FDA rules, 503A/503B compounding, state pharmacy board oversight, and how to get a legitimate prescription.
Is Sermorelin Legal in Massachusetts? Federal Rules, State Pharmacy Law, and How to Get a Prescription
A guide to Sermorelin's legal status in Massachusetts, covering FDA scheduling, 503A/503B compounding rules, the Massachusetts Board of Registration in Pharmacy, and how patients can lawfully obtain a prescription.
Is Sermorelin Legal in Tennessee? Prescription Rules, FDA Status, and How to Get It
A guide to Sermorelin's legal status in Tennessee, covering FDA compounding rules, 503A/503B pharmacy law, Tennessee Board of Pharmacy regulations, and how to obtain a legitimate prescription.
Is TB-500 Legal in Arizona? Federal Status, Prescriptions, and What Patients Need to Know
A guide to TB-500's legal status in Arizona, covering FDA regulations, 503A/503B compounding rules, state pharmacy board rules, and how to access TB-500 legally.
Is TB-500 Legal in Oregon? Federal Law, State Rules, and How to Get It
A complete guide to TB-500's legal status in Oregon, covering FDA regulations, the 503A/503B compounding framework, the Oregon Board of Pharmacy, and what patients need to know before seeking a prescription.
Is TB-500 Legal in Tennessee? How to Access It Legally
A complete guide to TB-500's legal status in Tennessee, covering FDA regulations, 503A/503B compounding pharmacy rules, state pharmacy board requirements, and how patients can access thymosin beta-4 peptide legally through a licensed provider.
Is Egrifta (Tesamorelin) Legal in Louisiana?
A complete guide to Egrifta (Tesamorelin) legal status in Louisiana, covering FDA approval, federal scheduling, 503A/503B compounding rules, Louisiana pharmacy board regulations, and how to obtain a legitimate prescription.
Is Thymosin Alpha-1 Legal in Colorado? How to Access It Legally
A complete guide to the legal status of Thymosin Alpha-1 in Colorado, covering FDA bulk-drug lists, 503A/503B compounding pharmacy rules, state pharmacy board requirements, and how to obtain a legitimate prescription.
Sermorelin Compounding Pharmacy FDA and State Board Enforcement History
A complete guide to FDA warning letters, USP <797> sterility standards, PCAB accreditation, and practical buyer guidance for sermorelin compounded peptides.
BPC-157 FDA Status 2026: What Patients and Prescribers Need to Know
A complete guide to BPC-157's FDA regulatory status in 2026, including the 503A/503B compounding ban, TB-500 status, how to verify a peptide COA, and what the 'research use only' label actually means.
Peptide Prescription Cost: What You'll Actually Pay in 2026
A breakdown of peptide prescription costs by compound, covering BPC-157, TB-500, GHK-Cu, CJC-1295/Ipamorelin, and insurance coverage realities for 2026.
Prometrium Adult (30 to 49) Safety: What You Need to Know
A guide to micronized progesterone (Prometrium) safety for adults aged 30 to 49, covering clinical evidence, side effects, drug interactions, and dosing guidelines.
Prometrium Food & Supplement Interactions: A Complete Clinical Guide
Micronized progesterone (Prometrium) is affected by food, grapefruit, St. John's Wort, and several other supplements through two distinct mechanisms: CYP3A4 metabolism and additive GABA-A sedation. Here is what is established, what is plausible but unproven, and how to think about timing your dose.
Prometrium Metabolism and Energy Expenditure: What the Clinical Evidence Actually Shows
A clinician-level review of how micronized progesterone (Prometrium) is metabolized, how it affects thermogenesis and resting energy expenditure, and what the PEPI trial and mechanistic literature tell prescribers.
Prometrium Post-Bariatric Surgery Use: What Clinicians and Patients Need to Know
Micronized progesterone (Prometrium) after bariatric surgery presents unique absorption, dosing, and monitoring challenges. This clinical guide covers pharmacokinetics, evidence, and practical protocols for post-bariatric HRT.
Prometrium in Special Populations: Transplant, HIV, Liver Disease, and More
A clinical deep-dive into micronized progesterone (Prometrium) use in special populations including solid-organ transplant recipients, people living with HIV, patients with liver disease, older adults, and those with metabolic conditions. Covers mechanisms, drug interactions, and evidence-based dosing guidance.
Prometrium Switching Guide: Moving Between Progestogens in HRT
A clinician-level guide to switching Prometrium (micronized progesterone) to or from other progestogens in hormone therapy, with trial data, mechanism of action, and step-by-step protocols.
Fosamax Global Regulatory Status: FDA Approval, Label Requirements, and Post-Market Safety
A complete guide to Fosamax (alendronate) regulatory history across the FDA, EMA, and major markets, including label changes, black-box warnings, and post-market safety findings.
AndroGel FDA Approval History: Complete Regulatory Timeline
A full regulatory history of AndroGel (testosterone gel 1% and 1.62%), from its 2000 FDA approval through post-market safety updates, label changes, and ongoing surveillance requirements.
Lipitor FDA Approval History: Atorvastatin's Regulatory Timeline Explained
A complete, clinically grounded look at Lipitor's FDA approval history, label changes, post-market safety updates, and what atorvastatin's regulatory record means for patients and prescribers today.
BPC-157 Pipeline, FDA Status, and What Comes Next
A complete regulatory and clinical overview of BPC-157: its current FDA status, compounding pharmacy classification, ongoing research pipeline, safety data, and what next-generation formulations may look like.
Vyleesi Global Regulatory Status: FDA Approval, Label, and Post-Market Safety
A complete guide to bremelanotide (Vyleesi) regulatory history, FDA-approved label details, global status, and post-market safety data. prepared by the HealthRX.com Editorial Team.
Cialis FAERS Safety Signals: What the FDA's Adverse Event Data Actually Shows
A clinician-focused review of Cialis (tadalafil) FAERS safety signals, FDA label history, post-market surveillance data, and what the adverse event database reveals about real-world risk.
Epitalon Label Updates 2020 to 2026: FDA Status, Safety Data, and Regulatory Timeline
A full regulatory and clinical review of epitalon tetrapeptide covering FDA status, no approved label, compounding restrictions, and published safety data from 2003 to 2026.
Oral Estradiol Label Updates 2020 to 2026: What Changed and Why It Matters
A complete regulatory history of oral estradiol FDA label changes from 2020 through 2026, covering boxed-warning revisions, post-market safety data, dosing guidance, and what prescribers and patients need to know today.
Finasteride Legal & Patent Challenges: FDA Approval, Label History, and Safety Litigation
A comprehensive review of finasteride's FDA approval timeline, patent disputes, generic entry, label evolution, post-market safety signals, and ongoing litigation, with primary-source citations throughout.
Addyi FDA Approval History: How Flibanserin Got to Market
A complete regulatory timeline of Addyi (flibanserin), including two FDA rejections, the 2015 approval, REMS requirements, labeling changes, and what the current prescribing label says about safety and dosing.
Addyi Global Regulatory Status: FDA Approval, Label Requirements, and International Availability
A comprehensive look at flibanserin (Addyi) regulatory history, FDA label requirements, REMS program, post-market safety data, and current availability outside the United States.
Ipamorelin Global Regulatory Status: FDA, EMA, and Compounding Rules Explained
A guide to ipamorelin's regulatory status worldwide, including FDA compounding restrictions, EMA standing, and what clinicians and patients need to know before prescribing or obtaining this growth hormone secretagogue.
Liraglutide EMA vs FDA Approach: Approval, Label, and Safety Compared
How the FDA and the European Medicines Agency evaluated, approved, and continue to monitor liraglutide (Victoza, Saxenda), including where the two labels genuinely diverge and where the difference is presentation rather than substance.
Liraglutide Global Regulatory Status: FDA, EMA, and Post-Market Safety
A complete guide to liraglutide's regulatory history across the FDA, EMA, and other agencies, including approved indications, label requirements, boxed warnings, and post-market surveillance findings.
Metformin Pipeline, FDA Regulatory History, and Next-Generation Formulations
A comprehensive look at metformin's FDA approval history, current label requirements, post-market surveillance findings, and what next-generation biguanide-class research means for clinical practice.
Crestor (Rosuvastatin) FDA Prescribing Info & Approval Status
FDA approved Crestor on August 12, 2003 (NDA 021366) for hyperlipidemia. Covers doses, black box warning, generics since 2016, and global approvals.
Egrifta (Tesamorelin) Legal and Patent Challenges: FDA Approval, Labeling, and Safety
A comprehensive review of Egrifta (tesamorelin) regulatory history, patent disputes, FDA labeling requirements, and post-market safety surveillance, with primary-source citations throughout.
Testosterone Cypionate FDA Approval History
A complete regulatory timeline of testosterone cypionate, from its 1979 FDA approval through post-market label updates, REMS requirements, and current prescribing guidance, with primary citations throughout.
Vaginal Estradiol Pipeline and Next-Gen Formulations: FDA Status, Label Updates, and What's Coming
A detailed look at the vaginal estradiol regulatory pipeline, current FDA-approved products, label requirements, post-market safety data, and emerging next-generation formulations in development.
Vardenafil (Levitra/Staxyn) FAERS Safety Signals: What the Post-Market Data Show
A comprehensive review of vardenafil FAERS adverse-event reports, FDA label warnings, post-market surveillance data, and clinical trial safety findings for Levitra and Staxyn.
Ambien Global Regulatory Status: FDA Approval, Label Requirements, and International Controls
A guide to zolpidem (Ambien) global regulatory status, covering FDA approval history, current labeling requirements, international scheduling, and post-market safety actions.
The Truth About Amlodipine: Real Side-Effect Reports
Ankle swelling affects about 10.8% of users at 10mg, the most common amlodipine side effect reported by patients and confirmed in FDA data and clinical trials.
AndroGel: What People Actually Pay and What Real Users Report
A data-driven look at AndroGel costs, real user reviews from Reddit and Drugs.com, clinical trial benchmarks, and what patients actually experience on testosterone gel therapy.
Trulicity Satisfaction Trends Over Time: What Real Users and Clinical Data Show
A detailed look at how Trulicity (dulaglutide) satisfaction changes from week one through year two, combining patient-reported experiences from Reddit, Drugs.com, and PatientsLikeMe with REWIND and AWARD trial data.
Prometrium: What People Actually Pay and What Real Patients Experience
Real cost data, patient reviews, and clinical evidence for Prometrium (micronized progesterone). Learn what women on HRT actually pay, what side effects they report, and how the drug compares to synthetic progestins.